GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)
India flag India · Delayed Price · Currency is INR
2,438.90
+22.20 (0.92%)
May 15, 2026, 3:29 PM IST

NSE:GLAXO Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
413,308386,822487,432329,173224,319281,714
Market Cap Growth
-12.99%-20.64%48.08%46.74%-20.37%15.45%
Enterprise Value
385,821366,569466,472313,334211,499270,099
Last Close Price
2438.802283.002843.281889.181257.081489.75
PE Ratio
39.9037.3452.5555.8036.7316.62
PS Ratio
10.429.7513.009.536.908.59
PB Ratio
18.2317.0624.9818.5212.8810.58
P/TBV Ratio
18.2817.1125.1518.7713.1410.72
P/FCF Ratio
48.7445.6238.4859.7650.9636.30
P/OCF Ratio
45.7642.8237.7956.5646.3334.75
EV/Sales Ratio
9.739.2412.449.076.508.24
EV/EBITDA Ratio
26.5225.2040.4735.5826.8336.36
EV/EBIT Ratio
27.7926.4141.8637.3528.2638.65
EV/FCF Ratio
45.5043.2336.8256.8948.0534.80
Debt / Equity Ratio
0.020.020.010.010.010.01
Debt / EBITDA Ratio
0.020.020.010.020.020.03
Debt / FCF Ratio
0.040.040.010.030.040.03
Net Debt / Equity Ratio
-1.21-1.21-1.27-1.03-0.94-1.06
Net Debt / EBITDA Ratio
-1.89-1.89-2.16-2.09-2.08-3.78
Net Debt / FCF Ratio
-3.24-3.24-1.96-3.34-3.72-3.62
Asset Turnover
0.940.940.981.000.820.85
Inventory Turnover
2.882.882.812.752.622.55
Quick Ratio
1.721.721.501.451.501.83
Current Ratio
2.032.031.791.841.882.18
Return on Equity (ROE)
49.11%49.11%49.75%33.53%27.59%18.39%
Return on Assets (ROA)
20.58%20.58%18.17%15.24%11.75%11.28%
Return on Invested Capital (ROIC)
---2875.95%-299.81%
Return on Capital Employed (ROCE)
54.50%54.50%50.60%41.30%37.40%23.80%
Earnings Yield
2.51%2.68%1.90%1.79%2.72%6.02%
FCF Yield
2.05%2.19%2.60%1.67%1.96%2.76%
Dividend Yield
4.10%-1.48%1.69%2.55%2.01%
Payout Ratio
68.92%68.92%80.79%91.80%249.80%29.89%
Buyback Yield / Dilution
-0.01%-0.01%----
Total Shareholder Return
4.10%-0.01%1.48%1.69%2.55%2.01%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.